Meta-analysis: Unresolved issues and future developments

British Medical Journal

Volumn 316, Issue 7126, 1998, Pages 221-225

  Smith, George Davey ^a   Egger, Matthias ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSTATISTICS; CLINICAL PRACTICE; DATA ANALYSIS; EPIDEMIOLOGY; MEDICAL LITERATURE; META ANALYSIS; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS;

EID: 3242657143     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.316.7126.221     Document Type: Review

References (40)

1. Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis. Methods for quantitative synthesis in medicine. New York: Oxford University Press, 1994.
2. Warren KS, Mosteller F, eds. Doing more good than harm. The evaluation of health care interventions. New York: New York Academy of Sciences, 1993.
3. Cooper H, Hedges LV, eds. The handbook of research synthesis. New York: Russell Sage Foundation, 1994.
4. Hedges LV, Olkin I. Statistical methods for meta-analysis. Boston: Academic Press, 1985.
5. Eddy DM, Hasselblad V, Shachter R. Meta-analysis by the confidence profile method. The statistical synthesis of evidence. Boston: Academic Press, 1992.
6. Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Science, 1994.
7. Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991.
8. Lilienfeld DE, Stolley PD. Foundations of epidemiology. New York: Oxford University Press, 1994.
9. Davey Smith G, Egger M, Phillips AN. Meta-analysis and data synthesis in medical research. In: Detels R, Holland WW, McEwen J, Omenn GS, eds. Oxford textbook of public health. New York: Oxford University Press (in press).
10. Egger M, Davey Smith G. Meta-analysis software (http.www.bmj.com).
11. Egger M, Davey Smith G. Meta-analysis: bias in location and selection of studies. BMJ 1998;316:61-6.
12. Cook DJ, Guyatt GH, Ryan G, Clifton J, Buckingham L, Willan A, et al. Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA 1993;269:2749-53.
13. Rennie D. Problems in peer review and fraud: cleave ever to the sunnier side of doubt. In: Balancing act. Essays to honour Stephen Lock. London: Keynes Press, 1991.
14. Nylenna M, Riis P, Karlsson Y. Multiple blinded reviews of the same two manuscripts: effects of referee characteristics and publication language. JAMA 1994;272:149-51.
15. Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1993;306:683-7.
16. Nakielny J. Effective and acceptable treatment for depression. BMJ 1993;306:1125.
17. Mandel EH, Rockette HE, Bluestone CD, Paradise JL, Nozza RJ. Efficacy of amoxicillin with and without decongestant-antihistamine for otitis media with effusion in children. New Engl J Med 1987;316:432-7.
18. Cantekin EI, McGuire TW, Griffith TL. Antimicrobial therapy for otitits media with effusion ("secretory" otitits media). JAMA 1991;266:3309-17.
19. Rennie D. The Cantekin affair. JAMA 1991;266:3333-7.
20. Subjectivity in data analysis [editorial]. Lancet 1991;337:401-2.
21. Begg CB, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-9.
22. Stewart LA, Parmar MKB. Meta-analysis of the literaure or of individual patient data: is there a difference? Lancet 1993;341:418-22.
23. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease. BMJ 1993;308:367-72.
24. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction; collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
25. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Graft Surgery Trialists Collaboration. Lancet 1994;344:563-70.
26. Takaro T, Hultgren HN, Lipton MJ, Detre KM. The VA cooperative randomized study of surgery for coronary arterial occlusive disease II: subgroup with significant left main lesions. Circulation 1976;54(suppl 3):107-17.
27. Clarke MJ, Stewart LA. Systematic reviews: obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses? BMJ 1994;309:1007-10.
28. Naylor CD. The case for failed meta-analyses. J Clin Eval Clin Pract 1995;1:127-30.
29. Egger M, Davey Smith G, Schneider M, Minder CE. Bias in meta-analysis detected by a simple, graphical test. BMJ;315:629-34.
30. Wardlaw J, Yamaguchi T, del Zoppo CJ, Hacke W. Thrombolysis in acute ischaemic stroke. In: Warlow C, van Gijn J, Sandercock P, eds. Stroke Module of the Cochrane Database of Systematic Reviews, [updated 03 June 1996]. Available in The Cochrane Library [database on disk and CD ROM]. The Cochrane Collaboration; Issue 2. Oxford: Update Software, 1996.
31. Cochrane A. Effectiveness and efficiency. Random reflections on health services. London: Nuffield Provincial Hospital Trust, 1972.
32. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;397-402.
33. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;ii:349-60.
34. Stampfer MJ, Goldhaber SZ, Yusuf S, Peto R, Hennekens CH. Effect of intravenous streptokinase on acute myocardial infarction. Pooled results from randomized trials. New Engl J Med 1982;307:1180-2.
35. Yusuf S, Collins R, Peto R, Furberg C, Stampfer MJ, Goldhaber SZ, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J 1985;6:556-85.
36. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. JAMA 1992;268:240-8.
37. Simoons ML, Serruys PW, van den Brand M, Bar F, de Zwaan C, Res J, et al. Improved survival after early thrombolysis in acute myocardial infarction. Lancet 1985;ii:578-82.
38. Gelber RD, Goldhirsch A. From the overview to the patient: how to interpret meta-analysis data. Recent Results in Cancer Research 1993;127:167-76.
39. Egger M, Davey Smith G. Misleading meta-analysis. Lessons from "an effective, safe, simple" intervention that wasn't. BMJ 1995;310:752-4.
40. Rosendaal FR. The emergence of a new species: the professional meta-analyst. J Clin Epidemiol 1994;47:1325-6.